RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31915254http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31915254http://www.w3.org/2000/01/rdf-schema#comment"Alzheimer's disease (AD) is the most common neurodegenerative disorder, resulting in the progressive decline of cognitive function in patients. Familial forms of AD are tied to mutations in the amyloid precursor protein, but the cellular mechanisms that cause AD remain unclear. Inflammation and amyloidosis from amyloid β (Aβ) aggregates are implicated in neuron loss and cognitive decline. Inflammation activates the protein-tyrosine phosphatase 1B (PTP1B), and this could suppress many signaling pathways that activate glycogen synthase kinase 3β (GSK3β) implicated in neurodegeneration. However, the significance of PTP1B in AD pathology remains unclear. Here, we show that pharmacological inhibition of PTP1B with trodusquemine or selective ablation of PTP1B in neurons prevents hippocampal neuron loss and spatial memory deficits in a transgenic AD mouse model with Aβ pathology (hAPP-J20 mice of both sexes). Intriguingly, while systemic inhibition of PTP1B reduced inflammation in the hippocampus, neuronal PTP1B ablation did not. These results dissociate inflammation from neuronal loss and cognitive decline and demonstrate that neuronal PTP1B hastens neurodegeneration and cognitive decline in this model of AD. The protective effect of PTP1B inhibition or ablation coincides with the restoration of GSK3β inhibition. Neuronal ablation of PTP1B did not affect cerebral amyloid levels or plaque numbers, but reduced Aβ plaque size in the hippocampus. In summary, our preclinical study suggests that targeting PTP1B may be a new strategy to intervene in the progression of AD.SIGNIFICANCE STATEMENT Familial forms of Alzheimer's disease (AD) are tied to mutations in the amyloid precursor protein, but the cellular mechanisms that cause AD remain unclear. Here, we used a mouse model expressing human amyloid precursor protein bearing two familial mutations and asked whether activation of a phosphatase PTP1B participates in the disease process. Systemic inhibition of this phosphatase using a selective inhibitor prevented cognitive decline, neuron loss in the hippocampus, and attenuated inflammation. Importantly, neuron-targeted ablation of PTP1B also prevented cognitive decline and neuron loss but did not reduce inflammation. Therefore, neuronal loss rather than inflammation was critical for AD progression in this mouse model, and that disease progression could be ameliorated by inhibition of PTP1B."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.org/dc/terms/identifier"doi:10.1523/jneurosci.2120-19.2019"xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/author"Zhang L."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/author"Qin Z."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/author"Chen H.H."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/author"Zasloff M.A."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/author"Stewart A.F.R."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/author"Cruz S.A."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/author"Farrokhi K."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/author"Ricke K.M."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/author"Sharmin F."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/date"2020"xsd:gYear
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/name"J Neurosci"xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/pages"1581-1593"xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/title"Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid beta-Associated Alzheimer's Disease in Mice."xsd:string
http://purl.uniprot.org/citations/31915254http://purl.uniprot.org/core/volume"40"xsd:string
http://purl.uniprot.org/citations/31915254http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31915254
http://purl.uniprot.org/citations/31915254http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/31915254
http://purl.uniprot.org/uniprot/#_E0CXT9-mappedCitation-31915254http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31915254
http://purl.uniprot.org/uniprot/#_E0CYH3-mappedCitation-31915254http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31915254
http://purl.uniprot.org/uniprot/#_E0CYJ9-mappedCitation-31915254http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31915254
http://purl.uniprot.org/uniprot/#_E0CX28-mappedCitation-31915254http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31915254
http://purl.uniprot.org/uniprot/#_E0CXK1-mappedCitation-31915254http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31915254
http://purl.uniprot.org/uniprot/#_P35821-mappedCitation-31915254http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31915254